ATLASRhythm Pharmaceuticals (RYTM) earnings date: Nov 3, 2026
Rhythm Pharmaceuticals (RYTM) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, before the open. Analysts expect EPS of -$0.68.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on RYTM
| Last price | $92.57 (-0.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.5% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Rhythm Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Rhythm Pharmaceuticals reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Rhythm Pharmaceuticals. You can switch it off at any time.
Alert me before RYTM reportsFree to start. Creating an account takes under a minute.
RYTM earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.68 |
| Last report | Aug 4, 2026 · Beat |
| Beat rate (last 4 reports) | 4 of 4 (100%) |
| Average EPS surprise | +49.0% |
| Average move around a report | ±7.3% (last 4) |
| Sector | Healthcare · Biotechnology |
Rhythm Pharmaceuticals earnings history: last 4 reports
Rhythm Pharmaceuticals last reported on Aug 4, 2026: EPS of -$0.73 against an estimate of -$0.83 (+12.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 4, 2026 | -$0.83 | -$0.73 | +12.0% | Beat | +7.7% |
| May 5, 2026 | -$0.86 | -$0.83 | +3.5% | Beat | +12.9% |
| Feb 25, 2026 | $0.16 | $0.43 | +168.8% | Beat | -0.6% |
| Jan 13, 2026 | $1.36 | $1.52 | +11.8% | Beat | +8.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for RYTM
See the fair value, the probability range and the earnings history of Rhythm Pharmaceuticals on its ATLAS page.
Rhythm Pharmaceuticals (RYTM) stock analysisPlans from €3.99 a month.
Rhythm Pharmaceuticals earnings: frequently asked questions
When does Rhythm Pharmaceuticals (RYTM) report earnings?
Rhythm Pharmaceuticals is scheduled to report on Tuesday, November 3, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for RYTM?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.68 per share (USD). Estimates can change before the report.
How often does RYTM beat earnings estimates?
Of its last 4 reports with a recorded result, Rhythm Pharmaceuticals beat the EPS estimate 4 times; the average surprise was +49.0%. Past results do not predict the next one.
How much does RYTM move around earnings?
Over its last 4 reports the stock moved an average of 7.3% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Rhythm Pharmaceuticals beat earnings estimates last quarter?
Rhythm Pharmaceuticals last reported on Aug 4, 2026: EPS of -$0.73 against an estimate of -$0.83 (+12.0% surprise), a beat.
How much does RYTM usually move in a day?
On a normal trading day the ATLAS model puts RYTM’s one-day range at about ±2.5%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer